Organon & Co OGN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/28/22 EDT
34.79UNCH (UNCH)
Volume
68,894
Close
34.79quote price arrow down-0.64 (-1.81%)
Volume
796,415
52 week range
28.42 - 39.48
Loading...
  • Open35.48
  • Day High35.60
  • Day Low34.66
  • Prev Close34.79
  • 52 Week High39.48
  • 52 Week High Date03/02/22
  • 52 Week Low28.42
  • 52 Week Low Date07/16/21

Key Stats

  • Market Cap8.824B
  • Shares Out253.64M
  • 10 Day Average Volume1.82M
  • Dividend1.12
  • Dividend Yield3.22%
  • Beta-
  • YTD % Change14.25

KEY STATS

  • Open35.48
  • Day High35.60
  • Day Low34.66
  • Prev Close34.79
  • 52 Week High39.48
  • 52 Week High Date03/02/22
  • 52 Week Low28.42
  • 52 Week Low Date07/16/21
  • Market Cap8.824B
  • Shares Out253.64M
  • 10 Day Average Volume1.82M
  • Dividend1.12
  • Dividend Yield3.22%
  • Beta-
  • YTD % Change14.25

RATIOS/PROFITABILITY

  • EPS (TTM)5.13
  • P/E (TTM)6.79
  • Fwd P/E (NTM)6.70
  • EBITDA (TTM)2.162B
  • ROE (TTM)75.12%
  • Revenue (TTM)6.365B
  • Gross Margin (TTM)63.00%
  • Net Margin (TTM)20.49%
  • Debt To Equity (MRQ)-727.52%

EVENTS

  • Earnings Date08/12/2022(est)
  • Ex Div Date05/13/2022
  • Div Amount0.28
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Organon & Co. (Organon) is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. Organon has a portfolio of contraception and fertility brands, such as Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. The Company’s Biosimilars portfolio spans across immunology and oncology treatments. It also...
Carrie Cox
Independent Chairman of the Board
Kevin Ali
Chief Executive Officer, Director
Matthew Walsh
Chief Financial Officer, Executive Vice President
Geralyn Ritter
Executive Vice President, Head of External Affairs and ESG
Rachel Stahler
Executive Vice President, Chief Information Officer
Address
30 Hudson Street, Fl 33
Jersey City, NJ
07302
United States

Top Peers

SYMBOLLASTCHG%CHG
ELAN
Elanco Animal Health Inc
20.14-0.34-1.66%
PRGO
Perrigo Company PLC
41.05-0.52-1.25%
RDY
Dr Reddy's Laboratories Ltd
55.29-0.36-0.65%
UTHR
United Therapeutics Corp
234.02-7.12-2.95%
CTLT
Catalent Inc
107.14-3.73-3.36%